Muscle Pain Treatment Market Report 2024

The muscle pain treatment market size has grown strongly in recent years. It will grow from $12.31 billion in 2023 to $12.95 billion in 2024 at a compound annual growth rate (CAGR) of 5.2%. During the historic period, growth was driven by factors such as an aging population experiencing higher rates of chronic pain, increased incidents of sports injuries from greater participation, the prevalence of musculoskeletal disorders in manual labor jobs, sedentary lifestyles contributing to muscle stiffness and pain, and reduced physical activity leading to muscle atrophy and pain.

The muscle pain treatment market size is expected to see strong growth in the next few years. It will grow to $15.96 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. Looking ahead to the forecast period, growth will be fueled by the increasing adoption of non-opioid and non-invasive pain management treatments, rising healthcare expenditures and demand for effective pain management solutions, regulatory approvals for new pain therapies and devices, emphasis on preventive healthcare to address chronic pain conditions, and rising interest in alternative therapies such as acupuncture and chiropractic care. Key trends in the forecast period include the integration of telehealth and virtual consultations for pain management, advancements in wearable pain relief devices and smart clothing, innovations in biopharmaceuticals for pain treatment, AI-driven personalized pain management solutions, and the application of regenerative medicine techniques for tissue repair and pain alleviation.

The muscle pain treatment market is expected to grow due to the increasing prevalence of musculoskeletal disorders. Musculoskeletal disorders affect the muscles, bones, and joints, causing pain, stiffness, and limited movement. Factors contributing to rising cases include aging populations, sedentary lifestyles, and the increasing incidence of chronic conditions. Treatment aims to alleviate symptoms by reducing pain, improving mobility, preventing complications, and enhancing overall quality of life and function. According to a November 2023 study by The Lancet, an estimated 494 million people globally experienced musculoskeletal disorders in 2020, with projections suggesting a potential 115% increase by 2050. As a result, the muscle pain treatment market is expanding.

Leading companies in this market are innovating by developing products such as topical analgesics to improve effectiveness and user convenience. These medications are applied directly to the skin to relieve pain in targeted areas, commonly used for muscle aches, arthritis, and minor injuries. For example, in July 2024, Wellness Formulations LLC introduced Ralli Rapid Pain Relief, featuring menthol for pain relief along with advanced penetration enhancers and skin conditioners. Available in gel, spray, and roll-on formats, it offers quick and long-lasting relief from muscle aches, joint pain, arthritis, strains, and sprains, without leaving a greasy residue. This allows for easy application directly to affected areas, eliminating the need for rubbing or massaging.

In February 2022, Athletico Physical Therapy, a US-based provider of physical therapy and orthopedic rehabilitation services, completed the acquisition of Pivot Health Solutions for an undisclosed sum. This strategic move strengthens Athletico's position in the muscle pain treatment market by expanding its geographic reach and enhancing capabilities in physical therapy and occupational health. The acquisition also brings seasoned leadership to Athletico and reinforces its commitment to delivering high standards of patient care. Pivot Health Solutions, also based in the US, specializes in physical therapy, occupational health, and onsite corporate health services, focusing on treating muscle pain and other physical ailments.

Major companies operating in the muscle pain treatment market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Haleon Plc, Select Medical Holdings Corporation, Purdue Pharma, Endo Pharmaceuticals Inc., Concentra Inc., Athletico Physical Therapy, ATI Physical Therapy Inc., Physiotherapy Associates Inc, NovaCare Rehabilitation Inc, CORA Health Services Inc., Select Physical Therapy Holdings Inc., ProActive Physical Therapy.

North America was the largest region in the muscle pain treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the muscle pain treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Treatment for muscle pain involves managing and easing discomfort and inflammation in muscles. This typically includes rest, applying heat or cold therapy, using over-the-counter pain relievers, and sometimes undergoing physical therapy or taking prescription medications for more severe cases. The goal of effective treatment is to reduce pain, facilitate healing, and restore normal muscle function.

Pharmacological approaches to treating muscle pain include analgesics, muscle relaxants, topical analgesics, and other medications. Analgesics are drugs specifically designed to alleviate pain without causing unconsciousness. Non-pharmacological treatments encompass physical therapy, massage therapy, acupuncture, heat and cold therapy, exercise, stretching, and other methods. These treatments target various types of pain, such as acute and chronic muscle pain resulting from overuse, injury, inflammation, neurological conditions, infections, and other causes. They are administered in various settings, including hospitals and clinics.

The muscle pain treatment market research report is one of a series of new reports that provides muscle pain treatment market statistics, including muscle pain treatment industry global market size, regional shares, competitors with a muscle pain treatment market share, detailed muscle pain treatment market segments, market trends and opportunities, and any further data you may need to thrive in the muscle pain treatment industry. This muscle pain treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The muscle pain treatment market consists of revenues earned by entities by providing services such as chiropractic care, hydrotherapy, occupational therapy, transcutaneous electrical nerve stimulation (TENS), cognitive-behavioral therapy (CBT), and myofascial release therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The muscle pain treatment market also includes sales of acetaminophen, corticosteroids, and nonsteroidal anti-inflammatory drugs (NSAIDs). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.